Alaunos Therapeutics Inc.
TCRT | NASDAQ
$1.26
+$0.06 (+5.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.26
$0 (0.00%)
Pre-market:
Sep 22, 2026, 5:51 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 3K | n/a | n/a | 2K | 4K | n/a | 4K | 1K | 1K | n/a | 4K | n/a | 11K | 2.91M | n/a | n/a | n/a | 398K | n/a | n/a |
Cost of Revenue | n/a | 8K | 361K | 469K | 185K | 347K | n/a | 143K | 180K | 2K | 933K | 1.06M | 5.19M | 696K | 3.11M | 691K | 685K | 689K | 705K | 12.32M | 679K | 540K |
Gross Profit | n/a | -8K | -358K | -469K | -185K | -345K | 4K | -143K | -176K | -1K | -932K | -1.06M | -5.18M | -696K | -3.1M | 2.22M | -685K | -689K | -705K | -11.92M | -679K | -540K |
Operating Income | -952K | -1.01M | -907K | -1.19M | -1.04M | -1.09M | -755K | -1.15M | -1.17M | -1.74M | -7.95M | -7.23M | -7.98M | -9.67M | -8.52M | -8.26M | -9.37M | -9.09M | -10.19M | -22.3M | -22.64M | -21.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -952K | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M | -22.67M | -21.55M |
Net Income | -952K | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M | -22.67M | -21.55M |
Selling & General & Admin | 564K | 585K | 549K | 718K | 854K | 747K | 845K | 1.01M | 990K | 1.62M | 2.43M | 2.51M | 3.05M | 2.47M | 2.93M | 2.59M | 2.74M | 2.82M | 1.39M | 6.87M | 8.39M | 7.69M |
Research & Development | 388K | 427K | 361K | 469K | 185K | 347K | -86K | 143K | 180K | 126K | 933K | 3.66M | 5.19M | 6.5M | 5.61M | 7.89M | 5.94M | 5.58M | 8.1M | 14.52M | 13.57M | 13.34M |
Other Expenses | n/a | -8K | -361K | -469K | -185K | -347K | n/a | -143K | -180K | n/a | 3.66M | n/a | -5.43M | n/a | -3.11M | n/a | n/a | n/a | n/a | -11.02M | n/a | n/a |
Operating Expenses | 952K | 1M | 549K | 718K | 854K | 747K | 759K | 1.01M | 990K | 1.74M | 7.02M | 6.17M | 2.8M | 8.98M | 5.43M | 10.48M | 8.68M | 8.4M | 9.49M | 10.37M | 21.96M | 21.02M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.07M | 853K | 888K | 841K | 740K | 683K | 738K | 444K | 31K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 1.01M | 910K | 1.19M | 1.04M | 1.09M | 759K | 1.15M | 1.17M | 1.74M | 7.95M | 7.23M | 7.99M | 9.67M | 8.53M | 11.18M | 9.37M | 9.09M | 10.19M | 22.69M | 22.64M | 21.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.43M | 1.95M | 1.95M | 2.18M | 1.68M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.49M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
Shares Outstanding (Diluted) | 2.43M | 1.95M | 1.95M | 2.18M | 1.68M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.49M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
EPS (Basic) | -0.41 | -0.59 | -0.40 | -0.55 | -0.63 | -0.67 | -0.46 | -0.70 | -0.71 | -1.05 | -4.90 | -5.30 | -5.49 | -5.85 | -6.58 | -6.58 | -6.84 | -7.32 | -8.24 | -15.89 | -15.86 | -15.11 |
EPS (Diluted) | -0.41 | -0.59 | -0.40 | -0.55 | -0.63 | -0.67 | -0.46 | -0.70 | -0.71 | -1.05 | -4.90 | -5.30 | -5.49 | -5.85 | -6.58 | -6.58 | -6.84 | -7.32 | -8.24 | -15.89 | -15.86 | -15.11 |
EBITDA | -952K | -998K | -886K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -3.12M | -7.41M | -7.53M | -8.5M | -5.33M | -7.32M | -8.51M | -8.42M | -10.35M | -21.62M | -21.99M | -21.01M |
EBIT | n/a | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -3.36M | -8.48M | -8.23M | -9.2M | -6.02M | -8.01M | -9.19M | -9.11M | -11.06M | -22.29M | -22.67M | -21.55M |
Depreciation & Amortization | n/a | 8K | 7K | n/a | 499 | n/a | -1K | n/a | 1K | 2K | 241K | 1.06M | 699K | 696K | 694K | 691K | 685K | 689K | 705K | 673K | 679K | 540K |
Add to Watchlist
Select watchlists to add or remove TCRT